Human mesenchymal stem cell biology;La biologie des cellules souches mésenchymateuses d'origine humaine

Medecine/Sciences

Volumn 27, Issue 3, 2011, Pages 261-267

  Charbord, Pierre ^a,b   Casteilla, Louis ^c,d  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Ecologie   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW CELL; HUMAN; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; PHYSIOLOGY; REGENERATION;

BONE MARROW CELLS; HUMANS; MESENCHYMAL STEM CELLS; MULTIPOTENT STEM CELLS; REGENERATION;

EID: 79954999148     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2011273261     Document Type: Article

References (41)

1. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970 ; 3 : 393-403.
2. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999 ; 284 :143-7. (Pubitemid 29282067)
3. Delorme B, Ringe J, Gallay N, et al. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 2008 111: 2631-5.
4. Charbord P, Livne E, Gross G, et al. Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience. Stem Cell Rev 2010 (online).
5. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008 ; 2 : 313-9. (Pubitemid 351467394)
6. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726-36.
7. Le Blanc K, Ringden O. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr Opin Immunol 2006 ; 18 : 586-91. (Pubitemid 44311450)
8. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007 ; 131: 324-36. (Pubitemid 47592917)
9. Sensebe L, Bourin P. Mesenchymal stem cells for therapeutic purposes. Transplantation 2009 ; 87 : S49-53.
10. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007;100:1249-60. (Pubitemid 46742916)
11. Noel D, Caton D, Roche S, et al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 2008 ; 314:1575-84.
12. Jansen BJ, Gilissen C, Roelofs H, et al. Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev 2010 ; 19: 481-90.
13. Loeffler M, Potten C. Stem cells and cellular pedigrees- a conceptual introduction. In : Potten C, ed. Stem cells. San Diego : Academic Press, 1997:1-28.
14. Loeffler M, Roeder I. Tissue stem cells: definition, plasticity, heterogeneity, self-organization and models - a conceptual approach. Cells Tissues Organs 2002 ; 171: 8-26. (Pubitemid 34522797)
15. Loeffler M, Roeder I. Conceptual models to understand tissue stem cell organization. Curr Opin Hematol 2004; 11: 81-7. (Pubitemid 38951225)
16. Huang S. Reprogramming cell fates: reconciling rarity with robustness. Bioessqys 2009 ; 31:546-60.
17. Kaern M, Elston TC, Blake WJ, Collins JJ. Stochasticity in gene expression: from theories to phenotypes. Nat Rev Genet 2005 , 6 :451-64. (Pubitemid 40733890)
18. Krinner A, Hoffmann M, Loeffler M, et al. Individual fates of mesenchymal stem cells in vitro. BMC Syst Biol 2010 ; 4 : 73.
19. Charbord P. Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gene Ther 2010 ; 21: 1045-56.
20. Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrowderived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99:8932-7. (Pubitemid 34693661)
21. Au P, Tarn J, Fukumura D, Jain RK. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008;111:4551-8.
22. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, etal. Fusion of bonemarrow-denved cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003 ; 425 : 968-73.
23. Barzilay R, Melamed E, Offen D. Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Stem Cells 2009 : 2509-15.
24. Takashima Y, Era T, Nakao K, et al. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007 ; 129 :1377-88. (Pubitemid 46970707)
25. Kuroda Y, Kitada M, Wakao S, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 2010 ; 107 : 8639-43.
26. Jiang y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Mature 2002 ; 418 :41-9.
27. Song L, Tuan RS. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. Faseb J 2004 ; 18 : 980-2. (Pubitemid 39561498)
28. Delorme B, Ringe J, Pontikoglou C, et al. Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity Stem Cells 2009 ; 27:1142-51.
29. Song L, Webb NE, Song y, Tuan RS. Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells 2006 ; 24 :1707-18. (Pubitemid 44474184)
30. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002 ; 13 : 4279-95. (Pubitemid 35471185)
31. Rodriguez AM, Pisani D, Dechesne CA, et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. ) Exp Med 2005 ; 201:1397-405. (Pubitemid 40664084)
32. Horwitz EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 2008 ; 10 : 771-4.
33. Kim y, Kim H, Cho H, et al. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 2007;20:867-76.
34. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999 ; 5 : 309-13. (Pubitemid 29124367)
35. ybon CH, Koyanagi M, Iekushi K, et al. Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: role of cardiovascular lineage commitment. Circulation 2010 ; 121: 2001-11.
36. Maggini J, Mirkin G, Bognanni I, et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 2010 ; 5 : e9252.
37. Corre J, Mahtouk K, Attal M, et al. Bone marrow mesenchymal stem cells are abnormal in multiple myeloma, leukemia 2007 ; 21:1079-88. (Pubitemid 46672085)
38. Menard C, Tarte K. Immunosuppression et cellules souches mésenchymateuses : mieux comprendre une propriété thérapeutique majeure. Med Sci (Paris) 2011 ; 27: 269-74.
39. Zipori D. À la recherche d'une définition moléculaire plus que descriptive pour les cellules souches. Med Sci (Pans) 2011 ; 27: 303-7.
40. Jorgensen C, Deschaseaux F, Planat-Benard V, Gabison E. Les cellules souches mésenchymateuses : actualités thérapeutiques. Med Sci (Paris) 2011;27:275-84.
41. Vinatier C, Bordenave L, Guicheux J, Amédée J. Les cellules souches en ingénierie des tissus ostéoarticulaires et vasculaires. Med Sci (Paris) 2011 ; 27:289-96.